Modification of von Willebrand Disease after Liver Transplantation

Thromb Haemost 2001; 86(06): 1588-1589
DOI: 10.1055/s-0037-1616772

Letters to the Editor

Schattauer GmbH

S. Schulman

¹Dept of Haematology, Karolinska Hospital, Stockholm

,

B.-G. Ericzon

²Dept of Transplantation Surgery

,

L. Eleborg

³Dept of Anesthesiology and Intensive Care, Huddinge University Hospital, Sweden

References
1 Gordon FH, Mistry PK, Sabin CA, Lee CA. Outcome of orthotopic liver transplantation in patients with haemophilia. Gut 1998; 42: 744-9.
2 Jaffe EA, Hoyer LW, Nachman RL. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest 1973; 52: 2757-64.
3 Nachman R, Levine R, Jaffe EA. Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J Clin Invest 1977; 60: 914-21.
4 Mannucci PM, Federici A, Cattaneo M, Fassati R, Galmarini D. Liver transplantation in severe von Willebrand disease. Lancet 1991; 337: 1105.
5 Bowie EJ, Woods JE, Fass DN, Zollman PE, Owen Jr CA. Liver transplantation in pigs with von Willebrand’s disease. Br J Haematol 1975; 31: 37-44.
6 Schimpf K, Rothmann P, Schumacher K. Comparison of factor VIII concentrates in non-bleeding patients. Scand J Haematol 1984; 33 (Suppl. 41) 131-45.
7 Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Wille-brand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol 1982; 95: 355-60.
8 Bichet DG, Razi M, Lonergan M, Arthus MF, Papukna V, Kortas C, Barjon JN. Hemodynamic and coagulation responses to 1-desamino[8-d-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med 1988; 318: 881-7.